GlassScriptPhysician profile
Linsie Zhang
NPI 1073299749
$4,206.90
in general payments reported to CMS, 2019-2025
13 companies · $2,924 in 2025
The $2,924 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,283 · 2025: $2,924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,975 · Education: $169 · Travel and Lodging: $62.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,975.42 |
| Education | $168.98 |
| Travel and Lodging | $62.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $615.92 | 2025 | Nemluvio, Aklief |
| Genzyme Corporation | $580.36 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $566.12 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $533.67 | 2025 | |
| Janssen Biotech, INC. | $474.48 | 2024-2025 | Tremfya |
| Abbvie INC. | $338.89 | 2024-2025 | |
| Ucb, INC. | $327.51 | 2024-2025 | Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.99 | 2025 | Spevigo |
| Arcutis Biotherapeutics, INC. | $145.09 | 2025 | Zoryve |
| Dermavant Sciences, INC. | $135.44 | 2024 | Vtama |
| Amgen INC. | $94.35 | 2025 | Otezla |
| Organon LLC | $79.16 | 2025 | Vtama |
| Incyte Corporation | $76.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linsie Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.